Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 16, 2019
HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediatorsŞule Kale, Aylin F Korcum, Ertuğrul Dündar, et al.Cancer Investigation|November 30, 2004
Prognostic role of Ebstein-Barr virus latent membrane protein-1 and interleukin-10 expression in patients with nasopharyngeal carcinomaEnis Ozyar, Ayşe Ayhan, Aylin F Korcum, et al.Life Sciences|January 12, 2022
Olvanil activates sensory nerve fibers, increases T cell response and decreases metastasis of breast carcinomaNuray Erin, Muhlis Akman, Elnur Aliyev, et al.Journal of Cancer Research and Therapeutics|March 30, 2026
Early changes in pulmonary function after stereotactic body radiotherapy for lung oligometastasesRahmi A Aksoy, Timur Koca, Sümeyye Çıtak, et al.Brain, Behavior, and Immunity|March 5, 2015
Activation of neuroimmune pathways increases therapeutic effects of radiotherapy on poorly differentiated breast carcinomaNuray Erin, Aylin F Korcum, Gamze Tanrıöver, et al.Breast Cancer Research and Treatment|June 14, 2013
Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinomaNuray Erin, Sule Kale, Gamze Tanrıöver, et al.International Journal of Radiation Oncology, Biology, Physics|May 22, 2007
TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinomaAhter D Sanlioglu, Aylin F Korcum, Elif Pestereli, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 2, 2009
Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical studyLale Atahan, Ferah Yildiz, Mustafa Cengiz, et al.Pageof 1